Clinical Trial Update: Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of vilaprisan in endometriosis was terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Vilaprisan (vilaprisan)

Snippet

Sponsor: Bayer | Conditions: Endometriosis | Phase 2 | Status: TERMINATED | Results posted: 2021-01-22